(Q47760929)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Guo-Zhong Fei

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Yi Hui Huang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jesper Swedenborg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

77-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

Atherosclerosis — An Inflammatory Disease

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Infectious agents and atherosclerotic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

The oxidation hypothesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Risk factors for cardiovascular disease in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-gamma production in lymphocytes from healthy individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Lysophosphatidylcholine Is Involved in the Antigenicity of Oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Autoantibodies to OxLDL are decreased in individuals with borderline hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

T-cell recognition of lipid peroxidation products breaks tolerance to self proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

Induction of T-cell activation by oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900146-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(03)00146-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860253%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference